Trademark: 90797989
Word
ESPRENTA
Status
Pending
Status Code
733
Status Date
Wednesday, May 22, 2024
Serial Number
90797989
Mark Type
4
Filing Date
Monday, June 28, 2021
Published for Opposition
Tuesday, April 12, 2022

Trademark Owner History
JOHNSON & JOHNSON - Owner At Publication

Classifications
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Events
Jul 1, 2021
New Application Entered
Sep 10, 2021
New Application Office Supplied Data Entered
Mar 8, 2022
Assigned To Examiner
Mar 10, 2022
Approved For Pub - Principal Register
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Apr 12, 2022
Published For Opposition
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2022
Sou Teas Extension Received
Nov 7, 2022
Sou Extension 1 Filed
Nov 7, 2022
Sou Extension 1 Granted
Nov 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 25, 2023
Sou Teas Extension Received
Apr 25, 2023
Sou Extension 2 Filed
Apr 25, 2023
Sou Extension 2 Granted
Apr 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2023
Sou Extension 3 Filed
Nov 29, 2023
Sou Extension 3 Granted
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2023
Sou Teas Extension Received
May 22, 2024
Sou Teas Extension Received
May 22, 2024
Sou Extension 4 Granted
May 22, 2024
Sou Extension 4 Filed
May 23, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24